Subsequent in vitro functional studies showed that the RPS27 5’UTR hotspot mutation decreases RPS27 mRNA levels and that decreased levels of RPS27 are associated with a worse prognosis of melanoma patients and drug (vemurafenib and palbociclib) sensitivity of melanoma cells (76). This evidence concerns the gene RPS27 and melanoma.